标题:Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial
作者:Zeng, Juan; Wang, Chun-Ting; Zhang, Fu-Shen; Qi, Feng; Wang, Shi-Fu; Ma, Shuang; Wu, Tie-Jun; Tian, Hui; Tian, Zhao-Tao; Zhang, Shu- 更多
作者机构:[Zeng, Juan; Wang, Chun-Ting; Chu, Yu-Feng; Meng, Mei; Ren, Hong-Sheng; Zhang, Ji-Cheng; Jiang, Jin-Jiao; Ding, Min; Wang, Yu-Ping] Shandong Univ, Sha 更多
通讯作者:Wang, CT
通讯作者地址:[Wang, CT]Shandong Univ, Shandong Prov Hosp, Dept Intens Care Unit, 324 Jingwu Rd, Jinan, Shandong, Peoples R China.
来源:INTENSIVE CARE MEDICINE
出版年:2016
卷:42
期:6
页码:1018-1028
DOI:10.1007/s00134-016-4303-x
关键词:Probiotics; Ventilator-associated pneumonia; Prevention and control;; Gastric colonization
摘要:Purpose: To evaluate the potential preventive effect of probiotics on ventilator-associated pneumonia (VAP).; Methods: This was an open-label, randomized, controlled multicenter trial involving 235 critically ill adult patients who were expected to receive mechanical ventilation for >= 48 h. The patients were randomized to receive (1) a probiotics capsule containing live Bacillus subtilis and Enterococcus faecalis (Medilac-S) 0.5 g three times daily through a nasogastric feeding tube plus standard preventive strategies or (2) standard preventive strategies alone, for a maximum of 14 days. The development of VAP was evaluated daily, and throat swabs and gastric aspirate were cultured at baseline and once or twice weekly thereafter.; Results: The incidence of microbiologically confirmed VAP in the probiotics group was significantly lower than that in the control patients (36.4 vs. 50.4 %, respectively; P = 0.031). The mean time to develop VAP was significantly longer in the probiotics group than in the control group (10.4 vs. 7.5 days, respectively; P = 0.022). The proportion of patients with acquisition of gastric colonization of potentially pathogenic microorganisms (PPMOs) was lower in the probiotics group (24 %) than the control group (44 %) (P = 0.004). However, the proportion of patients with eradication PPMO colonization on both sites of the oropharynx and stomach were not significantly different between the two groups. The administration of probiotics did not result in any improvement in the incidence of clinically suspected VAP, antimicrobial consumption, duration of mechanical ventilation, mortality and length of hospital stay.; Conclusion: Therapy with the probiotic bacteria B. Subtilis and E. faecalis are an effective and safe means for preventing VAP and the acquisition of PPMO colonization in the stomach.
收录类别:SCOPUS;SCIE
WOS核心被引频次:19
Scopus被引频次:18
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962191107&doi=10.1007%2fs00134-016-4303-x&partnerID=40&md5=554f2c537cbc2cdecf02620d622e1f48
TOP